Literature DB >> 12638728

Beta-amyloid precursor protein staining in nonhomicidal pediatric medicolegal autopsies.

R Ross Reichard1, Charles L White, Christa L Hladik, David Dolinak.   

Abstract

Immunohistochemical staining for beta-amyloid precursor protein (betaAPP) has been validated as a marker for axonal injury in adults surviving > or = 2 hours after white matter damage. The significance of betaAPP staining in pediatric brains and spinal cords is not as well established. We evaluated the white matter immunoreactivity for betaAPP from a variety of pediatric medicolegal autopsies: natural disease (non-Sudden Infant Death Syndrome [SIDS]), SIDS, motor vehicle accidents, drowning, near-drowning, overlay, carbon monoxide toxicity, miscellaneous trauma, and mechanical asphyxia. The cases of carbon monoxide toxicity, motor vehicle accidents (death at scene), drowning (with resuscitation), and a natural (non-SIDS) death had no significant white matter staining. The traumatic deaths with a significant survival interval, a variety of natural deaths, the near-drowning case, and surprisingly, all SIDS had detectable betaAPP white matter immunostaining. These results demonstrate that features other than traumatic axonal injury, such as metabolic insults and hypoxic-ischemic injury secondary to vascular compromise, must contribute to betaAPP immunostaining. In addition, we describe a variety of betaAPP-immunoreactive structures not previously reported in the pediatric population. This study illustrates that betaAPP immunostaining enhances detection of a variety of white matter changes, and provides a basis for interpretation of these results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12638728     DOI: 10.1093/jnen/62.3.237

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  4 in total

1.  Axonal injury in young pediatric head trauma: a comparison study of β-amyloid precursor protein (β-APP) immunohistochemical staining in traumatic and nontraumatic deaths.

Authors:  Michael W Johnson; Lisa Stoll; Ana Rubio; Juan Troncoso; Olga Pletnikova; David R Fowler; Ling Li
Journal:  J Forensic Sci       Date:  2011-05-19       Impact factor: 1.832

Review 2.  Protein accumulation in traumatic brain injury.

Authors:  Douglas H Smith; Kunihiro Uryu; Kathryn E Saatman; John Q Trojanowski; Tracy K McIntosh
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

3.  Intact interleukin-10 receptor signaling protects from hippocampal damage elicited by experimental neurotropic virus infection of SJL mice.

Authors:  Ann-Kathrin Uhde; Malgorzata Ciurkiewicz; Vanessa Herder; Muhammad Akram Khan; Niko Hensel; Peter Claus; Michael Beckstette; René Teich; Stefan Floess; Wolfgang Baumgärtner; Klaus Jung; Jochen Huehn; Andreas Beineke
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

4.  Repetitive mild traumatic brain injury in mice triggers a slowly developing cascade of long-term and persistent behavioral deficits and pathological changes.

Authors:  Xiaoyun Xu; Matthew Cowan; Flavio Beraldo; Amy Schranz; Patrick McCunn; Nicole Geremia; Zalman Brown; Maitray Patel; Karen L Nygard; Reza Khazaee; Lihong Lu; Xingyu Liu; Michael J Strong; Gregory A Dekaban; Ravi Menon; Robert Bartha; Mark Daley; Haojie Mao; Vania Prado; Marco A M Prado; Lisa Saksida; Tim Bussey; Arthur Brown
Journal:  Acta Neuropathol Commun       Date:  2021-04-06       Impact factor: 7.801

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.